Rankings
▼
Calendar
ZVRA Q4 2021 Earnings — Zevra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ZVRA
Zevra Therapeutics, Inc.
$618M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$3M
+9.1% YoY
Gross Profit
$3M
97.7% margin
Operating Income
-$3M
-110.1% margin
Net Income
-$3M
-104.7% margin
EPS (Diluted)
$-0.08
QoQ Revenue Growth
+31.4%
Cash Flow
Operating Cash Flow
-$848,000
Free Cash Flow
-$865,000
Stock-Based Comp.
$823,000
Balance Sheet
Total Assets
$133M
Total Liabilities
$6M
Stockholders' Equity
$127M
Cash & Equivalents
$112M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$3M
$2M
+9.1%
Gross Profit
$3M
$2M
+6.6%
Operating Income
-$3M
-$3M
+11.6%
Net Income
-$3M
-$5M
+44.3%
← FY 2021
All Quarters
Q1 2022 →